In conclusion, based on the Japan MS/NMOSD Biobank data, we show HLA genotype-clinical phenotype correlations concerning the confirmed and newly identified susceptibility and resistance DRB1 and DPB1 genes in Japanese patients with MS or NMOSD. Here, HLA-DPB1 is linked to myeloid sarcoma.